华东医药等新设股权投资合伙企业

Group 1 - A new investment partnership, Hangzhou Fuguang Hongze Equity Investment Partnership (Limited Partnership), has been established with a capital contribution of 2 billion [1] - The business scope of the partnership includes equity investment and venture capital, specifically limited to investments in unlisted companies [1] - The partnership is co-funded by East China Pharmaceutical and other entities [1]